4
Changes in Ownership
Atea Pharmaceuticals, Inc. Filed Acc 0000950170-25-013850
Chief Medical Officer gave up 16,071 shares (to pay taxes)
- Chief Medical Officer acquired 9,750 shares (grant or award)
- Chief Medical Officer acquired 41,533 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Horga Maria Arantxa Chief Medical Officer | 2025-01-31 | Option exercise | +41,533 | 67,197 | D | ||
| Horga Maria Arantxa Chief Medical Officer | 2025-01-31 | Grant or award | +9,750 | 76,947 | D | ||
| Horga Maria Arantxa Chief Medical Officer | 2025-01-31 | Shares withheld for taxes | −16,071 | $3.06 | $49,177 | 60,876 | D |
| Derivatives | |||||||
| Horga Maria Arantxa Chief Medical Officer | 2025-01-31 | Option exercise · Restricted Stock Units | −41,533 | 41,533 | D | ||
| Horga Maria Arantxa Chief Medical Officer | 2025-01-31 | Grant or award · Restricted Stock Units | +9,750 | 9,750 | D | ||
| Horga Maria Arantxa Chief Medical Officer | 2025-01-31 | Grant or award · Stock Option (Right to Buy) | +192,800 | 192,800 | D | ||
Loading xslF345X05/ownership.xml…